HDIM
DXCM icon

Hanson & Doremus Investment Management’s DexCom DXCM Stock Holding History

Hanson & Doremus Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54
Closed -$7K – 460
2024
Q1 		$7K Buy
+54
New +$6.79K ﹤0.01% 426

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hanson & Doremus Investment Management's DXCM Position: Q2 2024 in Review

Hanson & Doremus Investment Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 54 shares — an estimated $7K sold.

Hanson & Doremus Investment Management first reported a position in DXCM in Q1 2024 and held it in 1 quarter. The position peaked at $7K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Hanson & Doremus Investment Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 54 DexCom shares in Q2 2024, an estimated $7K.
  • Hanson & Doremus Investment Management first reported a position in DexCom in Q1 2024 and held it in 1 quarter.
  • Hanson & Doremus Investment Management's DexCom position peaked at $7K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.